Freestone Grove Partners LP Trans Medics Group, Inc. Transaction History
Freestone Grove Partners LP
- $8.16 Trillion
- Q4 2024
A detailed history of Freestone Grove Partners LP transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Freestone Grove Partners LP holds 3,865 shares of TMDX stock, worth $306,958. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,865Holding current value
$306,958% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TMDX
# of Institutions
345Shares Held
30.5MCall Options Held
671KPut Options Held
858K-
Vanguard Group Inc Valley Forge, PA3.64MShares$289 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$210 Million0.01% of portfolio
-
State Street Corp Boston, MA1.36MShares$108 Million0.0% of portfolio
-
Fil LTD Hamilton, D01MShares$79.4 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3993KShares$78.8 Million0.07% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $2.53B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...